Literature DB >> 8604622

Delineation of myocardial stunning and hibernation by positron emission tomography in advanced coronary artery disease.

A Conversano1, J F Walsh, E M Geltman, J E Perez, S R Bergmann, R J Gropler.   

Abstract

With positron emission tomography, the resting flow abnormalities underlying reversible left ventricular dysfunction in 17 patients with chronic coronary artery disease were delineated. The level of flow in reversible dysfuncTional segments (i.e., those demonstrating improvement after revascularization) was markedly variable, ranging from 0.32 to 1.25 ml/gm/min. In 20 of these segments, flow was preserved, whereas in 12 segments, flow was reduced, when compared with that in, age-matched controls. Preservation of flow was associated with preservation of myocardial oxygen consumption and no alterations in myocardial substrate use. In contrast, a reduction in flow resulted in a decrease myocardial oxygen consumption and an increase in myocardial glucose use. Thus resting reversible left ventricular dysfunction in patients with chronic coronary artery disease can reflect a diversity of resting flow abnormalities. Moreover, myocardial perfusion at rest is frequently within normal limits, suggesting that the reversible mechanical dysfunction in these patients is attributable to intermittent myocardial stunning and not hibernation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8604622     DOI: 10.1016/s0002-8703(96)90521-9

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  14 in total

Review 1.  Pathophysiology of myocardial hibernation. Implications for the use of dobutamine echocardiography to identify myocardial viability.

Authors:  J L Vanoverschelde; A Pasquet; B Gerber; J A Melin
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

Review 2.  Hibernating myocardium.

Authors:  R Schulz; G Heusch
Journal:  Heart       Date:  2000-12       Impact factor: 5.994

3.  Use of carbon 11-acetate for the measurement of myocardial oxygen consumption.

Authors:  O Akinboboye; S R Bergmann
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

4.  Methodology of a novel myocardial viability protocol.

Authors:  A E Iskandrian; E Acio
Journal:  J Nucl Cardiol       Date:  1998 Mar-Apr       Impact factor: 5.952

5.  Demonstration of intermittent ischemia and stunning in hibernating myocardium.

Authors:  Jeffrey M C Lau; Richard Laforest; Agus Priatna; Shivak Sharma; Jie Zheng; Robert J Gropler; Pamela K Woodard
Journal:  J Nucl Cardiol       Date:  2013-10       Impact factor: 5.952

6.  Coronary blood flow, metabolism, and function in dysfunctional viable myocardium before and early after surgical revascularisation.

Authors:  F Alamanni; A Parolari; A Repossini; E Doria; F Bortone; J Campolo; M Pepi; E Sisillo; M Naliato; R Bigi; P Biglioli; O Parodi
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

Review 7.  Recent advances in cardiac positron emission tomography in the clinical management of the cardiac patient.

Authors:  Robert J Gropler; Pablo Soto
Journal:  Curr Cardiol Rep       Date:  2004-01       Impact factor: 2.931

Review 8.  Hibernation and congestive heart failure.

Authors:  David P Dutka; Paolo G Camici
Journal:  Heart Fail Rev       Date:  2003-04       Impact factor: 4.214

Review 9.  Effects of brief ischemia and reperfusion on the myocardium and the role of nitric oxide.

Authors:  Christopher S R Baker; Sanjay Kumar; Ornella E Rimoldi
Journal:  Heart Fail Rev       Date:  2003-04       Impact factor: 4.214

10.  Flow-function relationships in chronic left-ventricular ischemic dysfunction: Impact of the transmurality of infarction.

Authors:  Bernhard L Gerber; Ho Thien Thanh; Véronique Roelants; Agnès Pasquet; David Vancraeynest; Jean-Louis J Vanoverschelde
Journal:  J Nucl Cardiol       Date:  2008-04-16       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.